SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

She’s a pediatrician, an asthma researcher at Harvard Medical School, and the mom of a 14-year-old who’s had asthma since she was a toddler, so Ann Chen Wu, M.D., knows how to look at asthma from ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

The treatment, which will be sold under the brand name Exdensur, is an “ultra-long-acting” version of a biologic treatment ...

What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...

More than 24 million Americans have been diagnosed with asthma, and 10 percent of them have a tough time controlling it, even with treatment. But a new form of therapy -- known as biologic -- is ...

Asthma is a lifelong condition with no cure, but there are many ways to manage your symptoms. Short-acting medications help you breathe when you’re having an attack. Long-term drugs work to keep ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

Six million American kids now have asthma—twice as many as 20 years ago. This mysterious epidemic panics parents, confounds doctors, and sends nearly 700,000 kids to the ER each year with I can't ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...